MASLD: the hidden liver disease rising with obesity and diabetes in the UK
TL;DR Summary
UK researchers found MASLD (metabolic dysfunction-associated steatotic liver disease), formerly called non-alcoholic fatty liver disease, is being diagnosed more often but a large diagnostic gap remains. Linked to obesity and type 2 diabetes, MASLD risks are higher for overweight individuals, the over-50s and those with high blood pressure; the study suggests routine screening and a blood test to estimate liver fibrosis could help detect advanced disease earlier.
- The middle-aged disease that makes you feel tired and often goes undiagnosed The Independent
- The Need for a More Dynamic Risk Assessment in Steatotic Liver Disease EMJ
- Rohit Loomba: Pleased to Share Our Review on MetALD Oncodaily
- Cases of liver disease linked to diabetes and obesity ‘up five-fold in a decade’ Doctors.net.uk
- Alcoholic Liver Disease Is Affecting Younger Indians BW Healthcare World
Reading Insights
Total Reads
1
Unique Readers
28
Time Saved
12 min
vs 13 min read
Condensed
97%
2,559 → 67 words
Want the full story? Read the original article
Read on The Independent